Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro

Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro

Abstract Effective vaccines are slowing the COVID-19 pandemic, but SARS-CoV-2 will likely remain an issue in the future making it important to have therapeutics to treat patients. There are few options for treating patients with COVID-19. We show probenecid potently blocks SARS-CoV-2 replication in...

Full description

Bibliographic Details
Main Authors: Jackelyn Murray, Robert J. Hogan, David E. Martin, Kathy Blahunka, Fred D. Sancilio, Rajiv Balyan, Mark Lovern, Richard Still, Ralph A. Tripp
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-97658-w

Internet

https://doi.org/10.1038/s41598-021-97658-w

Similar Items